MedPath

A study to evaluate skin moisturization.

Not Applicable
Completed
Registration Number
CTRI/2023/05/052885
Lead Sponsor
Sami-Sabinsa Group Ltd
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
30
Inclusion Criteria

1. Healthy female subjects, as determined from a recent medical history.

2. Subjects in the age group of 18-45 years (both ages inclusive).

3. Subjects who present normal to dry skin on the forearm (corneometer value of

35 as maximum)

4. Healthy skin in the test sites.

5. Subjects willing to give voluntary written informed consent and agree to come

for regular follow-up.

6. Subjects willing to abide by and comply with the study protocol.

7. Subjects who are willing not to participate in any other clinical study during participation in the current study.

Exclusion Criteria

1. Excessive hair on the test site

2. A known history or present condition of an allergic response to any cosmetic

products.

3. Change personal nutrition habits as well as sports habits

4. Start or change their oral hormonal treatment or their oral contraception.

5. Subject having active skin diseases (e.g., active atopic dermatitis, pigmented

contact dermatitis or other cutaneous manifestations), which will interfere with

the assessment.

6. Subjects on oral medications (e.g. steroids, anti-oxidant) which will

compromise the study.

7. Subjects had cancer in the last 10 years

8. Subjects with wounds, sunburn, scars, tattoos or piercings at the skin test

site(s)

9. Subjects with application of ointments, creams etc. for antibacterial, anti allergic or immunosuppressive treatment of the skin at the test site(s)

10.Systemic treatment which may modify the cutaneous state on the day of

inclusion or in the previous 30 days, including retinoid therapy.

11. History of intense sun exposure and/ photo toxicity/allergy.

12.Female subjects who are pregnant, lactating or nursing.

13.Chronic illness which may influence the cutaneous state.

14.Subject participating in any other cosmetic or therapeutic trial.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. To evaluate and compare skin moisturization using Corneometer – CM 825 with a single application of the test product in comparison to the baseline and untreated control. <br/ ><br>2. To evaluate the retention of skin moisturization for immediate, 4 hours, 8 hours, and 24 hours using Corneometer – CM 825 with a single application of the test product in comparison to the untreated site. <br/ ><br>3. To evaluate the deep moisturization: TEWL with a single application of the test product in comparison to the untreated site. <br/ ><br>4. To measure and compare TEWL at immediate, 4 hours, 8 hours, and 24 hours with a single application of the test product in comparison to the baseline and untreated control. Timepoint: Baseline, Immediate, 4 hours, 8 hours and 24 hours
Secondary Outcome Measures
NameTimeMethod
To evaluate the efficacy based on the dermatological visual assessment at immediate, 4 hours, 8 hours, and 24 hours with a single application of the test product compared to the baseline and untreated control.Timepoint: Baseline, Immediate, 4 hours, 8 hours and 24 hours
© Copyright 2025. All Rights Reserved by MedPath